NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
NCT04112641
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
DRUG:
Nicotinamide riboside
DRUG:
Placebo capsules
Sponsor
Donna Hammond, PhD